![Meng Yao Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meng Yao Chen
Direktor/Vorstandsmitglied bei Vita Genomics, Inc.
Profil
Meng Yao Chen is currently a Director at Vita Genomics, Inc. Prior to this, he was a Director & Deputy General Manager at Hakers Enterprise Co. Ltd.
Aktive Positionen von Meng Yao Chen
Unternehmen | Position | Beginn |
---|---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Direktor/Vorstandsmitglied | 12.08.2010 |
Ehemalige bekannte Positionen von Meng Yao Chen
Unternehmen | Position | Ende |
---|---|---|
HAKERS ENTERPRISE CO., LTD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HAKERS ENTERPRISE CO., LTD. | Consumer Non-Durables |
Private Unternehmen | 1 |
---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |